{"entity":{"id":"nct01761968","kind":"trial","name":"Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms","aka":[],"tldr":"A phase 2 trial of Givinostat in myeloproliferative neoplasms, run by Italfarmaco, active and no longer recruiting.","summary":"Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms is a phase 2 interventional study registered as NCT01761968 by Italfarmaco, with 90 participants enrolled, started 2013-03 and due to reach its primary completion in 2026-12. Interventions recorded: givinostat.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT01761968","url":"https://clinicaltrials.gov/study/NCT01761968"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["myeloproliferative-neoplasms"],"sections":[],"technologies":[],"targets":[],"drugs":["givinostat"],"companies":["italfarmaco"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT01761968","phase":"2","setting":"Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms","sponsor":"Italfarmaco","enrolled":90,"outcomes":[]},"route":"/trials/nct01761968/","neighbours":{"cancer":[{"id":"myeloproliferative-neoplasms","kind":"cancer","name":"Myeloproliferative neoplasms (PV, ET, myelofibrosis)","route":"/cancers/myeloproliferative-neoplasms/"}],"drug":[{"id":"givinostat","kind":"drug","name":"Givinostat","route":"/drugs/givinostat/"}],"company":[{"id":"italfarmaco","kind":"company","name":"Italfarmaco","route":"/companies/italfarmaco/"}]}}